239 related articles for article (PubMed ID: 16461568)
1. Enumeration and immunohistochemical characterisation of bone marrow basophils in myeloproliferative disorders using the basophil specific monoclonal antibody 2D7.
Agis H; Krauth MT; Mosberger I; Müllauer L; Simonitsch-Klupp I; Schwartz LB; Printz D; Böhm A; Fritsch G; Horny HP; Valent P
J Clin Pathol; 2006 Apr; 59(4):396-402. PubMed ID: 16461568
[TBL] [Abstract][Full Text] [Related]
2. Identification of basogranulin (BB1) as a novel immunohistochemical marker of basophils in normal bone marrow and patients with myeloproliferative disorders.
Agis H; Krauth MT; Böhm A; Mosberger I; Müllauer L; Simonitsch-Klupp I; Walls AF; Horny HP; Valent P
Am J Clin Pathol; 2006 Feb; 125(2):273-81. PubMed ID: 16393678
[TBL] [Abstract][Full Text] [Related]
3. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
Lanza F; Bi S; Castoldi G; Goldman JM
Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
[TBL] [Abstract][Full Text] [Related]
6. Expression of the basophil-specific antibodies 2D7 and BB1 in patients with cutaneous Mastocytosis.
Idoate MA; Echeveste J; Gil P; Sanz ML; Ferrer M
J Investig Allergol Clin Immunol; 2013; 23(6):392-7. PubMed ID: 24459815
[TBL] [Abstract][Full Text] [Related]
7. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
8. Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.
Jordan JH; Jäger E; Sperr WR; Schwarzinger I; Födinger M; Fritsche-Polanz R; Ohler L; Geissler K; Valent P
Eur J Clin Invest; 2003 Jul; 33(7):611-8. PubMed ID: 12814399
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of human basophils in late-phase skin reactions.
Irani AM; Huang C; Xia HZ; Kepley C; Nafie A; Fouda ED; Craig S; Zweiman B; Schwartz LB
J Allergy Clin Immunol; 1998 Mar; 101(3):354-62. PubMed ID: 9525452
[TBL] [Abstract][Full Text] [Related]
10. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal cells in myeloproliferative disorders.
Hirata J; Takahira H; Kaneko S; Nishimura J; Nawata H
Acta Haematol; 1989; 82(1):35-9. PubMed ID: 2505472
[TBL] [Abstract][Full Text] [Related]
12. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
14. Chronic myeloid leukaemia: evidence for basophil differentiation and histamine synthesis from cultured peripheral blood cells.
Denburg JA; Wilson WE; Goodacre R; Bienenstock J
Br J Haematol; 1980 May; 45(1):13-21. PubMed ID: 6929704
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia.
Valent P; Agis H; Sperr W; Sillaber C; Horny HP
Leuk Lymphoma; 2008 Apr; 49(4):635-8. PubMed ID: 18398724
[TBL] [Abstract][Full Text] [Related]
17. Identification and partial characterization of a unique marker for human basophils.
Kepley CL; Craig SS; Schwartz LB
J Immunol; 1995 Jun; 154(12):6548-55. PubMed ID: 7759888
[TBL] [Abstract][Full Text] [Related]
18. [Blood histamine level in chronic myeloproliferative diseases; a review].
Gingold N
Onkologie; 1979 Apr; 2(2):70-4. PubMed ID: 392372
[TBL] [Abstract][Full Text] [Related]
19. Characterization of leukaemic basophil progenitors from chronic myelogenous leukaemia.
Teshima T; Kondo S; Harada M; Shibuya T; Okamura T; Tamari Y; Kimura N; Akashi K; Okamura S; Niho Y
Br J Haematol; 1991 May; 78(1):55-9. PubMed ID: 2043482
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity in Philadelphia positive chronic myeloid leukaemia.
Rasoul NA; Elhalawani N; Nafae MH; Elkaffash DM; Mourad ZI
Egypt J Immunol; 2004; 11(1):1-8. PubMed ID: 15724380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
